1. Home
  2. ASMB vs WEYS Comparison

ASMB vs WEYS Comparison

Compare ASMB & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$20.29

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$51.87

Market Cap

486.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
WEYS
Founded
2005
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
486.0M
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
ASMB
WEYS
Price
$20.29
$51.87
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $52.00
N/A
AVG Volume (30 Days)
★ 202.1K
27.2K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 2.21%
EPS Growth
★ 91.78
N/A
EPS
N/A
★ 2.04
Revenue
N/A
★ $276,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$24.75
Revenue Growth
★ N/A
N/A
52 Week Low
$19.94
$27.25
52 Week High
$39.71
$53.83

Technical Indicators

Market Signals
Indicator
ASMB
WEYS
Relative Strength Index (RSI) 31.31 61.69
Support Level N/A $30.78
Resistance Level $30.36 $53.83
Average True Range (ATR) 1.10 1.44
MACD 0.10 -0.25
Stochastic Oscillator 7.07 42.31

Price Performance

Historical Comparison
ASMB
WEYS

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

Share on Social Networks: